Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy

Ian C. Marschner, Ann C. Collier, Robert W. Coombs, Richard T. D'Aquila, Victor DeGruttola, Margaret A. Fischl, Scott M. Hammer, Michael D. Hughes, Victoria A. Johnson, David A. Katzenstein, Douglas D. Richman, Laura M. Smeaton, Stephen A. Spector, Michael S. Saag

Research output: Contribution to journalArticle

188 Scopus citations

Fingerprint Dive into the research topics of 'Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences